Telesis Bio Inc. Quarterly Cost of Revenue in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Telesis Bio Inc. quarterly/annual Cost of Revenue history and growth rate from Q2 2020 to Q2 2024.
  • Telesis Bio Inc. Cost of Revenue for the quarter ending June 30, 2024 was $2.35M, a 15.2% increase year-over-year.
  • Telesis Bio Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $10.1M, a 7.58% decline year-over-year.
  • Telesis Bio Inc. annual Cost of Revenue for 2023 was $10.6M, a 10.8% decline from 2022.
  • Telesis Bio Inc. annual Cost of Revenue for 2022 was $11.8M, a 75.6% increase from 2021.
  • Telesis Bio Inc. annual Cost of Revenue for 2021 was $6.74M, a 129% increase from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Quarterly (USD)
Cost of Revenue, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $10.1M $2.35M +$310K +15.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $9.75M $1.99M -$811K -28.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 $10.6M $3.15M +$125K +4.14% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 $10.4M $2.57M -$449K -14.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 $10.9M $2.04M -$904K -30.7% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $11.8M $2.81M -$53K -1.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 $11.8M $3.02M +$827K +37.7% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-29
Q3 2022 $11M $3.02M +$1.39M +85.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 $9.62M $2.94M +$1.04M +55% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 $8.58M $2.86M +$1.83M +179% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q4 2021 $6.74M $2.2M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-22
Q3 2021 $1.62M +$885K +120% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.9M +$1.28M +206% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.03M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
Q3 2020 $739K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $620K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.